These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 33085633)
1. Clinical performance of calcitonin and procalcitonin Elecsys Giovanella L; Fontana M; Keller F; Verburg FA; Ceriani L Clin Chem Lab Med; 2021 Mar; 59(4):743-747. PubMed ID: 33085633 [TBL] [Abstract][Full Text] [Related]
2. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163 [TBL] [Abstract][Full Text] [Related]
3. Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma. Kratzsch J; Willenberg A; Frank-Raue K; Kempin U; Rocktäschel J; Raue F Clin Chem Lab Med; 2021 Oct; 59(11):1861-1868. PubMed ID: 34256421 [TBL] [Abstract][Full Text] [Related]
4. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma. Parra-Robert M; Orois A; Augé JM; Halperin I; Filella X; Molina R Clin Chem Lab Med; 2017 Mar; 55(3):441-446. PubMed ID: 27754959 [TBL] [Abstract][Full Text] [Related]
5. Negative predictive value of procalcitonin in medullary thyroid carcinoma. Lim SK; Guéchot J; Vaubourdolle M Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393 [TBL] [Abstract][Full Text] [Related]
6. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection. Kaczka K; Mikosiński S; Fendler W; Celnik A; Pomorski L Adv Clin Exp Med; 2012; 21(2):169-78. PubMed ID: 23214280 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen. Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679 [TBL] [Abstract][Full Text] [Related]
8. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules. Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer. Jeong IY; Yun HJ; Kim SM; Park Y Diagnostics (Basel); 2024 Aug; 14(16):. PubMed ID: 39202297 [TBL] [Abstract][Full Text] [Related]
10. Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review. Karagiannis AK; Girio-Fragkoulakis C; Nakouti T Anticancer Res; 2016 Aug; 36(8):3803-10. PubMed ID: 27466480 [TBL] [Abstract][Full Text] [Related]
11. Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows. Censi S; Di Stefano M; Repaci A; Benvenuti T; Manso J; Pagotto U; Iacobone M; Barollo S; Bertazza L; Galuppini F; Benna C; Pennelli G; Plebani M; Faggian D; Colombo C; Fugazzola L; Mian C Front Endocrinol (Lausanne); 2021; 12():754565. PubMed ID: 34721303 [TBL] [Abstract][Full Text] [Related]
12. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900 [TBL] [Abstract][Full Text] [Related]
13. Can procalcitonin be useful for medullary thyroid cancer? Kaczka K; Mikosiński S; Fendler W; Jałocha-Kaczka A; Pomorski L Endokrynol Pol; 2010; 61(5):430-6. PubMed ID: 21049453 [TBL] [Abstract][Full Text] [Related]
14. Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma. Giovanella L; Fontana M; Keller F; Campenni' A; Ceriani L; Paone G Clin Chem Lab Med; 2021 Aug; 59(9):1569-1573. PubMed ID: 33860650 [TBL] [Abstract][Full Text] [Related]
15. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays? Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502 [No Abstract] [Full Text] [Related]
16. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules. Giovanella L; Verburg FA; Imperiali M; Valabrega S; Trimboli P; Ceriani L Clin Chem Lab Med; 2013 Jul; 51(7):1477-81. PubMed ID: 23314540 [TBL] [Abstract][Full Text] [Related]
17. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature. Trimboli P; Giovanella L Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697 [TBL] [Abstract][Full Text] [Related]
18. Elevated Procalcitonin Levels can Occur in Bacterial Infections and also in Medullary Thyroid Carcinoma. Kaya F; Alsafdi T Eur J Case Rep Intern Med; 2024; 11(7):004679. PubMed ID: 38984187 [TBL] [Abstract][Full Text] [Related]
19. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma. Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993 [TBL] [Abstract][Full Text] [Related]
20. Other markers of medullary thyroid cancer, not only calcitonin. Censi S; Manso J; Mian C Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]